|
¡¡»ÒµÜðô¤¬¤ó¤Ï¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¡ÊHPV¡Ë´¶À÷¤ò¸¶°ø¤È¤¹¤ë´â¤Ç¤¢¤ê¡¢ÆüËܤǤâËèǯÌó1Ëü5Àé¿Í¤ÎÊý¤¬È¯¾É¤·¡¢Ìó3Àé500¿Í¤ÎÊý¤¬¤ªË´¤¯¤Ê¤ê¤Ë¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£ ¡¡¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¤Ï¡¢¤¹¤Ù¤Æ¤Î½÷À¤ÎÌó80¡ó¤¬°ìÀ¸¤Ë°ìÅ٤ϴ¶À÷¤·¤Æ¤¤¤ë¤ÈÊó¹ð¤¬¤¢¤ë¤Û¤É¤¢¤ê¤Õ¤ì¤¿¥¦¥¤¥ë¥¹¤Ç¤¹¡£ ¡¡Â¿¤¯¤Î¾ì¹ç¡¢À¸ò¾Ä¤Ë¤è¤Ã¤Æ´¶À÷¤¹¤ë¤È¹Í¤¨¤é¤ì¤Æ¤ª¤ê¡¢À¹Ôư¤Î¤¢¤ë¤¹¤Ù¤Æ¤Î½÷À¤¬»ÒµÜðô¤¬¤ó¤Ë¤Ê¤ë²ÄǽÀ¤ò»ý¤Ã¤Æ¤¤¤Þ¤¹¡£ ¡¡¶áǯ¡¢»ÒµÜðô¤¬¤óͽËÉHPV¥ï¥¯¥Á¥ó¤¬³«È¯¤µ¤ì¡¢¥ï¥¯¥Á¥óÀܼï¤Ë¤è¤ê¥¦¥¤¥ë¥¹´¶À÷¤òͽËɤ·¡¢¾ÍèŪ¤Ê»ÒµÜðô¤¬¤ó¤Îȯ¾É¿ô¤ò¸º¤é¤¹¤³¤È¤¬´üÂÔ¤µ¤ì¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡£ ¡¡¤³¤ÎHPV¥ï¥¯¥Á¥ó¤¬ËÜË®¤Ç¤â¤è¤¦¤ä¤¯¾µÇ§¤µ¤ì¤¿¤È¤³¤í¤Ç¤¹¤¬¡¢¸½»þÅÀ¤Ç¤ÏǤ°ÕÀܼï¤Ç¤¢¤ê¡¢3²ó¤ÎÀܼï¤Ë¹ç·×¤ÇÌó5Ëü±ßÁ°¸å¤ÎÈñÍѤ¬É¬ÍפȤʤê¤Þ¤¹¡£ ¡¡¤è¤ê¿¤¯¤Î½÷À¤Ç¤ÎÀܼ郎²Äǽ¤È¤Ê¤ë¤è¤¦¤Ë¡¢½ô³°¹ñ¤Ç¤Ï¹ñ¤Î¥ï¥¯¥Á¥óÀ¯ºö¤ËÁÈ¤ßÆþ¤ì¤ë¤³¤È¤¬¿ä¾©¤µ¤ì¤Æ¤ª¤ê¡¢¤Û¤È¤ó¤É¤ÎÀè¿Ê¹ñ¤Ç¤ÏÀܼïÈñÍѤËÂФ·¸øÈñ½õÀ®¤¬¤Ê¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ ¡¡²æ¤¬¹ñ¤Ë¤ª¤¤¤Æ¤â¤è¤ê¿¤¯¤ÎÆüËܽ÷À¤Î·ò¹¯¤ò¼é¤ë¤¿¤á¤Ë¡¢»ÒµÜðô¤¬¤óͽËÉHPV¥ï¥¯¥Á¥ó¤Î¸øÈñ½õÀ®¤Ë¤è¤ëÉéô·Ú¸º¤òµá¤á¤Þ¤¹¡£ ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡Ê¿À®22ǯ1·î13Æü ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¹ñΩ¤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡É±¡Ä¹¡¡ ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡Æâ³ÕÉÜ¡¡µ¬À©²þ³×²ñµÄÀìÌç°Ñ°÷ ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡ÅÚ²°¡¡Î»²ð ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡·ÄØæµÁ½ÎÂç³ØÁí¹çÀ¯ºö³ØÉôÁí¹çÀ¯ºö³Ø²ÊÀìǤ¹Ö»Õ ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡½©»³¡¡Èþµª ½ð̾Ê罸ÅŻҽð̾Ê罸[SSLÂбþ] ½ð̾¤Ë»¿Æ±¤¤¤¿¤À¤±¤ëÊý¤Ï°Ê²¼¤è¤ê½ð̾(SSLÂбþ)¤ò¤ª´ê¤¤Ãפ·¤Þ¤¹¡£²¿Â´¤´¶¨ÎϤè¤í¤·¤¯¤ª´ê¤¤¿½¤·¾å¤²¤Þ¤¹¡£ ·ÈÂÓ¤«¤é¤Ï¡¡¡¡http://bit.ly/hpvvaccination¡¡¡¡¤Ç½ð̾²Äǽ¤Ç¤¹¡£ »ÒµÜðô¤¬¤óͽËɥ說¥Á¥óÀܼï¤Î¸øÈñ½õÀ®¤ò[SSLÂбþ] »ÒµÜðô¤¬¤ó¤Ï¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¡ÊHPV¡Ë´¶À÷¤ò¸¶°ø¤È¤¹¤ë´â¤Ç¤¢¤ê¡¢ÆüËܤǤâËèǯÌó1Ëü5Àé¿Í¤ÎÊý¤¬È¯¾É¤·¡¢Ìó3Àé500¿Í¤ÎÊý¤¬¤ªË´¤¯¤Ê¤ê¤Ë¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¤Ï¡¢¤¹¤Ù¤Æ¤Î½÷À¤ÎÌó80¡ó¤¬°ìÀ¸¤Ë°ìÅ٤ϴ¶À÷¤·¤Æ¤¤¤ë¤ÈÊó¹ð¤¬¤¢¤ë¤Û¤É¤¢¤ê¤Õ¤ì¤¿¥¦¥¤¥ë¥¹¤Ç¤¹¡£Â¿¤¯¤Î¾ì¹ç¡¢À¸ò¾Ä¤Ë¤è¤Ã¤Æ´¶À÷¤¹¤ë¤È¹Í¤¨¤é¤ì¤Æ¤ª¤ê¡¢À¹Ôư¤Î¤¢¤ë¤¹¤Ù¤Æ¤Î½÷À¤¬»ÒµÜðô¤¬¤ó¤Ë¤Ê¤ë²ÄǽÀ¤ò»ý¤Ã¤Æ¤¤¤Þ¤¹¡£¶áǯ¡¢»ÒµÜðô¤¬¤óͽËÉHPV¥ï¥¯¥Á¥ó¤¬³«È¯¤µ¤ì¡¢¥ï¥¯¥Á¥óÀܼï¤Ë¤è¤ê¥¦¥¤¥ë¥¹´¶À÷¤òͽËɤ·¡¢¾ÍèŪ¤Ê»ÒµÜðô¤¬¤ó¤Îȯ¾É¿ô¤ò¸º¤é¤¹¤³¤È¤¬´üÂÔ¤µ¤ì¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡£¤³¤ÎHPV¥ï¥¯¥Á¥ó¤¬ËÜË®¤Ç¤â¤è¤¦¤ä¤¯¾µÇ§¤µ¤ì¤¿¤È¤³¤í¤Ç¤¹¤¬¡¢¸½»þÅÀ¤Ç¤ÏǤ°ÕÀܼï¤Ç¤¢¤ê¡¢3²ó¤ÎÀܼï¤Ë¹ç·×¤ÇÌó5Ëü±ßÁ°¸å¤ÎÈñÍѤ¬É¬ÍפȤʤê¤Þ¤¹¡£¤è¤ê¿¤¯¤Î½÷À¤Ç¤ÎÀܼ郎²Äǽ¤È¤Ê¤ë¤è¤¦¤Ë¡¢½ô³°¹ñ¤Ç¤Ï¹ñ¤Î¥ï¥¯¥Á¥óÀ¯ºö¤ËÁÈ¤ßÆþ¤ì¤ë¤³¤È¤¬¿ä¾©¤µ¤ì¤Æ¤ª¤ê¡¢¤Û¤È¤ó¤É¤ÎÀè¿Ê¹ñ¤Ç¤ÏÀܼïÈñÍѤËÂФ·¸øÈñ½õÀ®¤¬¤Ê¤µ¤ì¤Æ¤¤¤Þ¤¹¡£²æ¤¬¹ñ¤Ë¤ª¤¤¤Æ¤â¤è¤ê¿¤¯¤ÎÆüËܽ÷À¤Î·ò¹¯¤ò¼é¤ë¤¿¤á¤Ë¡¢»ÒµÜðô¤¬¤óͽËÉHPV¥ï¥¯¥Á¥ó¤Î¸øÈñ½õÀ®¤Ë¤è¤ëÉéô·Ú¸º¤òµá¤á¤Þ¤¹¡£ Ê¿À®22ǯ1·î13Æü ¹ñΩ¤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡±¡Ä¹ Æâ³ÕÉܵ¬À©²þ³×²ñµÄÀìÌç°Ñ°÷ ÅÚ²°Î»²ð ·ÄØæµÁ½ÎÂç³ØÁí¹çÀ¯ºö³ØÉôÁí¹çÀ¯ºö³Ø²ÊÀìǤ¹Ö»Õ ½©»³Èþµª Ëܼñ»Ý¤Ë¤´»¿Æ±¤¤¤¿¤À¤±¤Þ¤¹³§Íͤ«¤é¤Î¤´½ð̾¤ò¤ª´ê¤¤¤¤¤¿¤·¤Þ¤¹¡£ ÅŻҥ᡼¥ë¤Î¥¢¥É¥ì¥¹¤ò¤´µÆþ¤Î¾å¡¢Ï¢Íí¤Î²ÄÈݤÎÍó¤ò²Ä¤Ë¤·¤Æ¤¤¤¿¤À¤¤¤¿Êý¤Ë¤Ï¡¢ËÜ·ï´ØÏ¢¤Î¥Ë¥å¡¼¥¹¤ò¤ªÃΤ餻¤¤¤¿¤·¤Þ¤¹¡£ ¥×¥é¥¤¥Ð¥·¡¼¥Ý¥ê¥·¡¼ ¤´½ð̾¤Î¤¿¤á¤Ë¤¤¤¿¤À¤¤¤¿¤ªÌ¾Á°Åù¸Ä¿Í¾ðÊó¤Ï½ð̾°Ê³°¤ÎÌÜŪ¤Ë»È¤¦¤³¤È¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£½ð̾Äó½ÐÀè¤Ë¤Ï¡¢¸Ä¿Í¾ðÊó¤Ë¤Ä¤¼è¤ê°·¤¤¤Ëα°Õ¤·¤Æ¤¯¤À¤µ¤ë¤è¤¦¿½¤·Æþ¤ì¤ò¹Ô¤¤¤Þ¤¹¡£¸Ä¿Í¾ðÊó¤ò¡¢½ð̾Äó½ÐÀè°Ê³°¤ÎÂè»°¼Ô¤Ë³«¼¨¡¦Äó½Ð¤¹¤ë¤³¤È¤Ï¤´¤¶¤¤¤Þ¤»¤ó¡£´ÉÍý¤ÏËܽð̾Ê罸¼Â¹Ô°Ñ°÷²ñ»ö̳¶É¤ÇŬÀڤ˹Ԥ¤¤Þ¤¹¡£ Äɵ »ñÎÁ ¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¡ÊHPV¡Ë¤ÎVLP ¥ï¥¯¥Á¥ó¤Î¸¶Íý HPV ¤ÏºÙ˦ÇÝÍܷϤÇÁý¿£¤·¤Ê¤¤¤Î¤Ç¡¢¤½¤ì¤ËÂå¤ï¤ëÁȤßÂØ¤¨DNA µ»½Ñ¤òÍѤ¤¤¿¹çÀ®·Ï¤¬³«È¯¤µ¤ì¤¿¡£ ¹çÀ®¤µ¤ì¤ë¤Î¤Ï°äÅÁ»Ò¤ò»ý¤¿¤Ê¤¤¥¦¥¤¥ë¥¹ÍÍγ»Ò¡Êvirus-like particle¡§VLP¡Ë¤Ç¤¢¤ë¡¢´¶À÷À¤Ï¤Ê¤¤¡¢ÅŸ²¤Ç¤Ï¼«Á³¤ÎHPV γ»Ò¤È³°´Ñ¾åƱÍͤÎΩÂι½Â¤¤ò»ý¤Ä¡¢¹ÚÊì¶ÝºÙ˦¡Êyeast¡Ë¤Þ¤¿¤Ïº«ÃîºÙ˦¡Êrecombinantbaculovirus¡Ë¤ÇL1 ¤Þ¤¿¤ÏL1.L2 ¤òȯ¸½¤µ¤»¡¢selfassembly¤¹¤ë¤³¤È¤Ë¤è¤ê¹çÀ®¤µ¤ì¤ë¡¢Êƹñ¥á¥ë¥¯¼Ò¤Ïyeast ¤òÍѤ¤¡¢GSK ¤Ïbaculovirus ¤òÍѤ¤¤Æ¤¤¤ë¡£ VLP ¤Ë¤Ï¡¢L1¡Êmajor capsid protein¡Ë¤À¤±¤«¤é¤Ê¤ë¤â¤Î¤È¼«Á³¤ÎHPV γ»ÒƱÍͤËL1 ¤ª¤è¤ÓL2¡Êminorcapsid protein¡Ë¤«¤é¤Ê¤ë¤â¤Î¤¬¤¢¤ë¤¬¡¢¥ï¥¯¥Á¥ó¤È¤·¤Æ¤ÏL1-VLP ¤¬ÍѤ¤¤é¤ì¤Æ¤¤¤ë¡¢GARDASIL ¤Ç¤Ï HPV6¡¤11¡¤16¡¤18 ¤¬20¦Ìg¡¤40¦Ìg¡¤40¦Ìg¡¤20¦Ìg ´Þ¤Þ¤ì¤ë¡¥¥¢¥ë¥ß¥Ë¥¦¥à¤ò´Þ¤à¥¢¥¸¥å¥Ð¥ó¥È¤òÍѤ¤¡¤1 ²ó0.5mL ¤Ç3 ²óÀܼï¡Ê0 ¥«·î¡¤2 ¥«·î¡¤6 ¥«·î¡Ë¡¤¶ÚÃí¤Ç¤¢¤ë¡¥CERVARIX ¤Ç¤ÏÂè2 ²óÌܤÎÀܼï¤Ï1 ¥«·î¸å¤Ç¤¢¤ë¡£ L1-VLP ¤Ï¼«Á³¤ÎHPV γ»Ò¤ÈƱÍͤǡ¤Ä¾·Â55nm¤Ç¤¢¤ê¡¤Ê¬»ÒÎÌ55,000 ¤ÎL1 ÃÁÇò¤¬5 ʬ»Ò¤Ç1capsomere¤ò·ÁÀ®¤·¡¤72 ¸Ä¤Îcapsomere ¤¬ÀµÆó½½ÌÌÂξå¤ËÇÛÎ󤷤ơ¤1 ¤Ä¤ÎVLP ¤È¤Ê¤ë¡ÊFig. 1¡Ë¡¥HPV ´¶À÷¤ÏÈéÉæ¡¦Ç´Ë컽ýÉô¤Î´ðÄìºÙ˦¡Ê¾åÈé´´ºÙ˦¡Ë¤Ë¡¤¥¦¥¤¥ë¥¹Î³»Ò¡Êvirion¡Ë¤È¤·¤Æ¿¯Æþ¤¹¤ë¤³¤È¤«¤é»Ï¤Þ¤ë¤¬¡¤L1-VLP ¥ï¥¯¥Á¥ó¤Ë¤è¤êͶƳ¤µ¤ì¤¿ÃæÏ¹³ÂΤ¬¥¦¥¤¥ë¥¹Î³»Ò¤Ë·ë¹ç¤¹¤ë¤³¤È¤Ë¤è¤ê´¶À÷¤ò¥Ö¥í¥Ã¥¯¤¹¤ë¡ÊFig. 2¡Ë¡¥¤Ä¤Þ¤ê¡¢±ÕÀÌȱ֤ˤè¤ë¤â¤Î¤Ç¤¢¤ê¡¢HPV ´¶À÷¤Î¼«Á³¾ÃÂà¡Êviral clearance¡Ë¤È¤Ï°Û¤Ê¤ê¡¤ºÙ˦ÀÌȱ֤ϴØÍ¿¤·¤Ê¤¤¡¥¤·¤¿¤¬¤Ã¤Æ¡¢Í½Ëɸú²Ì¤Ï¤¢¤Ã¤Æ¤â¼£ÎŸú²Ì¤Ï¤Ê¤¤¡¥ ËÜȯÌÀ¤Ï¡¢¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹´¶À÷¾É¤Î¼£ÎŵڤÓͽËɤËÍÍѤÊÊýË¡µÚ¤ÓÁÈÀ®Êª¤Ë´Ø¤¹¤ë¡£ ¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¡ÊHPV¡Ë¥ï¥¯¥Á¥ó¤Î¸½¾õ¤È²ÝÂê The present status and significance in implementation of prophylactic human papillomavirus vaccine in Japan ¥â¥À¥ó¥á¥Ç¥£¥¢¡¡55 ´¬10 ¹æ2009¡ÎÌÈ±Ö¡Ï 269 ¶âÂô°å²ÊÂç³Ø¡¦À¸¿£¼þ»º´ü°å³Ø¡¦½Ú¶µ¼ø ºû¡¡Àî¡¡¼÷¡¡Ç· ¡Ì¥¦¥¤¥ë¥¹¡¡Âè58 ´¬¡¡Âè2 ¹æ¡¤pp.155-164¡¤2008¡Í 2. HPV ¥ï¥¯¥Á¥ó¤Ë¤è¤ë»ÒµÜðô´âͽËÉ °æ¾å¡¡Àµ¼ù ¶âÂôÂç³Ø°å³Ø·Ï¸¦µæ²Ê»ºÉØ¿Í²Ê³Ø http://www.jstage.jst.go.jp/article/jsv/58/2/155/_pdf/-char/ja/ ¡¡¡¡¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý¡Ý £Ç£Ó£Ë¤Î¥¢¥¸¥å¥Ð¥ó¥É£Á£Ó£°£´¤Ç¤Î¥ê¥¹¥¯¤Ë¤Ä¤¤¤Æ¤Ï¡£ Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials ÌÜŪ ¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¡§HPVͽËÉÀܼï¤á¤Ëή»º¤Î´í¸±À¤¬¹â¤Þ¤«¤«¤É¤É¤¦¤«¤òɾ²Á¤¹¤ë¡£ 4ǯ¤Î´Ñ»¡´ü´ÖÃæ¤Ë3599¤ÎÇ¥¿±¤¬¤¢¤Ã¤¿¡¢14¥ö¹ñ¡¢15¡Ý25ºÐ¤Î½÷À26130̾¤òÂоݤȤ·¤¿2·ï¤Î̵ºî°Ù²½Èæ³Ó»î¸³¤ò²òÀϤ·¡¢¥Ò¥È¥Ñ¥Ô¥í¡¼¥Þ¥¦¥¤¥ë¥¹¡ÊHPV¡Ë¥ï¥¯¥Á¥ó¤Èή»º¥ê¥¹¥¯¤Î´ØÏ¢¤ò¸¡¾Ú¡£¿äÄêή»ºÎ¨¤Ï¡¢HPV¥ï¥¯¥Á¥ó·²11.5¡ó¡¢ÂоȤÎA·¿´Î±ê¥ï¥¯¥Á¥ó·²10.2¡ó¤Ç¤¢¤ê¡¢Í°Õº¹¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£Ãø¼Ô¤é¤Ï¡¢HPV¥ï¥¯¥Á¥ó¤Èή»º¥ê¥¹¥¯¤Ë´ØÏ¢¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¤È·ëÏÀ ÀܼïºÇ¸å¤«¤é90Æü°ÊÆâ¤Îή»ºÎ¨¤Ï¡¢HPV¥ï¥¯¥Á¥ó·²13.7¡ó¡¢A·¿´Î±ê¥ï¥¯¥Á¥ó·²9.2¡ó¡¡PÃÍ= 0.033¡£Àܼﷲ¤¬ÈóÀܼﷲ¤è¤ê¤â¹â¤¤¤³¤È¤¬»ØÅ¦¡£
ÀܼïºÇ¸å¤«¤é90Æü°Ê¾å¸å¤Îή»ºÎ¨¤Ï¡¢HPV¥ï¥¯¥Á¥ó·²¡Ê130¡Ë10.5%¤ÈÈóÀܼﷲ¡Ê134¡Ë10.7%¡£ |

- >
- Yahoo!¥µ¡¼¥Ó¥¹
- >
- Yahoo!¥Ö¥í¥°
- >
- Îý½¬ÍÑ





2010/2/15(·î) ¸áÁ° 9:48 ¤µ¤ó
À¸¥ï¥¯¥Á¥ó¡Ê¼åÆÇÀ¡Ë¤Ç¤Ê¤¤¡¢ÉÔ³èÀ¥ï¥¯¥Á¥ó¤Ê¤é¡¢Ê¡È¿±þ¤Ï¡¢¾¯¤Ê¤¤¤È»×¤¤¤Þ¤¹¡£
£°¤Ç¤Ï¡¢¤¢¤ê¤Þ¤»¤ó¤¬¡¢ÉÔ³èÀ¥¹¥×¥ê¥Ã¥È³ô¥ï¥¯¥Á¥ó¤ÈÌîÀ¸¸¶¼ï³ô¤È¤Ç¤Ï¡¢¤Ç¤·¤ç¤¦¤«¡£
·ì±ÕÀ½ºÞ¤â´í¸±¤È¤â¤Ê¤ê¤Þ¤¹¤«¤é¡¢³Î¤«¤ËÉԳμÂÀ¤ò¿¤¯´Þ¤ß¤Þ¤¹¤¬¡¢»È¤ï¤Ê¤¤¤ÈµßÌ¿¡¢¸å°ä¾É¤ÎÌäÂê²ò·è¤¬ÉÔ²Äǽ¤Ê¾ì¹ç¤â¤¢¤ê¤Þ¤¹¤·¡£
±¿°¤¯¡¢ÉûÈ¿±þ¤Ç¡¢¤Î¤«¤¿¤Ë¤Ï¡¢¹ñ²ÈÊä½þ¤¬É¬ÍפǤ¢¤ë»ö¤Ï¡¢ÅöÁ³¤Ç¤¹¤¬¡£
HPV16·¿¡¢18·¿¤Ç¡¢»ÒµÜðô¤¬¤óȯÀ¸¤È¡¢¥ï¥¯¥Á¥ó¤Ç¤ÎÉûÈ¿±þ¤òÈæ¤Ù¤¿¤é¡¢Èæ¤Ç¤Ï¤Ê¤¤¤è¤¦¤Ê¤¤¬¤·¤Þ¤¹¡£
2010/2/15(·î) ¸áÁ° 10:36 [ ¤ª¤ß¤¾ ]
HPV16,18¤Ç6³ä¤¯¤é¤¤¤Ç¤·¤¿¤è¤Í¡£GSK¤«¤é»ñÎÁ¤ò¤¤¤¿¤À¤¤¤Æ¤ª¤ê¤Þ¤¹¡£HPV¤â·¿¤¬Â¿¤¯¤Æº¤¤Ã¤¿¤â¤Î¤Ç¤¹¤Í¡£¤¢¤È¤Ï¥¢¥¸¥å¥Ð¥ó¥È¡£³«¶È°å¤Ç¤Ï¤¤¤Þ¤Ò¤È¤ÄȽÃÇÉÕ¤¤Þ¤»¤ó¡£¤³¤Î¥¢¥¸¥å¥Ð¥ó¥È¤ÏÁêÅö¼ð¤ì¤ë¤È¤â¦ʹ¤·¤Æ¤ª¤ê¤Þ¤¹¡£
2010/2/18(ÌÚ) ¸áÁ° 4:52 [ kasiyama255 ]
kasiyama255 ÀèÀ¸
GSK¤Î¥¢¥¸¥å¥Ð¥ó¥É¤Ï¡¢AS04 ¡§¥¢¥ë¥ß¥Ë¥¦¥à±ö¡¢¥ê¥ó»À²½»é¼ÁA ¤Ç¤¹¤Î¤Ç¡¢¥ª¥¤¥ë¥¿¥¤¥×AS03¤Ë¡¢Èæ¤Ù¤ë¤È¡¢¶É½ê¤Î¼ð¤ì¤Ï¾¯¤Ê¤¤¤è¤¦¤Ë¤Î¤â»×¤¨¤Þ¤¹¡£VLP ¥ï¥¯¥Á¥ó¤Ç¤¹¤Î¤Ç¡¢¥¢¥¸¥å¥Ð¥ó¥É¤¬¤Ê¤¤¤È¡¢»ý³À¤¬¾¯¤Ê¤¯¤Ê¤Ã¤Æ¤·¤Þ¤¦¤³¤È¤Ç¤¹¤Í¡£ HPV¤Ï¡¢¸¶ÂΤκÙ˦Áý¿£¤¬¤Ç¤¤Ê¤¤»ö¤¬¡£
2010/2/18(ÌÚ) ¸áÁ° 10:43 [ ¤ª¤ß¤¾ ]
Áᮡ¢½ð̾¤µ¤»¤Æ¤¤¤¿¤À¤¤Þ¤·¤¿
ÅöÊý¤Ç¤â¤´ÅöÃϤλºÉؿͲʤÎÀèÀ¸¤«¤é¹Ö±é¤òĺ¤¤Þ¤·¤¿
http://blogs.yahoo.co.jp/fuzitashin/31275443.html
2010/2/22(·î) ¸áÁ° 8:23 [ ¥í¡¼¥È¥ë°å»Õ ]
¥í¡¼¥È¥ë°å»Õ ÀèÀ¸
¤ª¤Ï¤è¤¦¤´¤¶¤¤¤Þ¤¹¡£
¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£»ä¤¬¸À¤¦¤Î¤â¥Ø¥ó¤Ç¤¢¤ê¤Þ¤¹¤¬¡£
»Ò¶¡¼êÅö¤Æ¤Ï¡¢¥ï¥¯¥Á¥ó¤Î̵ÎÁ²½¤Ç¡¢¤ª´ê¤¤¤·¤¿¤¤¤Ç¤¹¡£
2010/2/22(·î) ¸áÁ° 11:24 [ ¤ª¤ß¤¾ ]